ANL 10.56 Decreased By ▼ -0.04 (-0.38%)
ASC 9.31 Decreased By ▼ -0.01 (-0.11%)
ASL 11.75 Decreased By ▼ -0.15 (-1.26%)
AVN 80.50 Decreased By ▼ -0.16 (-0.2%)
BOP 5.55 No Change ▼ 0.00 (0%)
CNERGY 5.48 Decreased By ▼ -0.02 (-0.36%)
FFL 6.75 No Change ▼ 0.00 (0%)
FNEL 6.00 Decreased By ▼ -0.05 (-0.83%)
GGGL 11.30 Decreased By ▼ -0.13 (-1.14%)
GGL 16.83 Decreased By ▼ -0.05 (-0.3%)
GTECH 8.73 Decreased By ▼ -0.08 (-0.91%)
HUMNL 7.39 Increased By ▲ 0.12 (1.65%)
KEL 3.07 Decreased By ▼ -0.05 (-1.6%)
KOSM 3.15 No Change ▼ 0.00 (0%)
MLCF 27.15 Increased By ▲ 0.25 (0.93%)
PACE 3.20 Increased By ▲ 0.10 (3.23%)
PIBTL 6.17 Increased By ▲ 0.07 (1.15%)
PRL 18.50 No Change ▼ 0.00 (0%)
PTC 7.12 Increased By ▲ 0.01 (0.14%)
SILK 1.19 No Change ▼ 0.00 (0%)
SNGP 34.09 Increased By ▲ 0.04 (0.12%)
TELE 11.39 Decreased By ▼ -0.01 (-0.09%)
TPL 9.44 Decreased By ▼ -0.10 (-1.05%)
TPLP 20.65 Decreased By ▼ -0.06 (-0.29%)
TREET 30.20 No Change ▼ 0.00 (0%)
TRG 78.08 Decreased By ▼ -0.22 (-0.28%)
UNITY 20.53 Decreased By ▼ -0.02 (-0.1%)
WAVES 12.84 Decreased By ▼ -0.01 (-0.08%)
WTL 1.43 Decreased By ▼ -0.02 (-1.38%)
YOUW 4.99 Increased By ▲ 0.05 (1.01%)
BR100 4,172 Increased By 12.4 (0.3%)
BR30 15,372 Decreased By -15.7 (-0.1%)
KSE100 42,004 Increased By 125.1 (0.3%)
KSE30 16,067 Increased By 58.1 (0.36%)
Pakistan

DRAP permits clinical trials of plasma therapy for Coronavirus treatment: Zafar Mirza

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ve
09 Apr, 2020
  • The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.
  • More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.
  • The companies will prepare quality sanitizers as per the directions of the World Health Organization.

ISLAMABAD: Special Assistant to the Prime Minister on National Health Services, Dr. Zafar Mirza Thursday announced that Drug Regulatory Authority of Pakistan (DRAP) has allowed the local production of raw material of cholorquine as part of efforts to cope with coronavirus challenge.

In a statement, he said the DRAP has also permitted clinical trials of plasma therapy for coronavirus treatment, Electronic/Radio channel reported.

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.

More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.

The companies will prepare quality sanitizers as per the directions of the World Health Organization.

Comments

Comments are closed.